Freeman L, Archibald A, Dive L, Delatycki M, Kirk E, Laing N
Eur J Hum Genet. 2024; 33(2):194-198.
PMID: 39587355
PMC: 11840106.
DOI: 10.1038/s41431-024-01738-0.
Schnabel-Besson E, Mutze U, Dikow N, Horster F, Morath M, Alex K
Int J Neonatal Screen. 2024; 10(3).
PMID: 39311364
PMC: 11417796.
DOI: 10.3390/ijns10030062.
Tonnies H, Nennstiel U
Med Genet. 2024; 34(1):1-2.
PMID: 38836012
PMC: 11006363.
DOI: 10.1515/medgen-2022-2119.
Lynch F, Best S, Gaff C, Downie L, Archibald A, Gyngell C
Hum Genomics. 2024; 18(1):45.
PMID: 38720401
PMC: 11077791.
DOI: 10.1186/s40246-024-00611-x.
Veldman A, Kiewiet M, Westra D, Bosch A, Brands M, de Coo R
Int J Neonatal Screen. 2023; 9(4).
PMID: 37873847
PMC: 10594494.
DOI: 10.3390/ijns9040056.
[Newborn blood spot screening (NBS) in Germany : Status quo and presentation of a concept for further development].
Nennstiel U, Odenwald B, Throner V, Blankenstein O, Vieth A, Ratzel R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023; 66(11):1195-1204.
PMID: 37815611
PMC: 10622373.
DOI: 10.1007/s00103-023-03771-8.
Scaling-up and future sustainability of a national reproductive genetic carrier screening program.
Fehlberg Z, Best S, Long J, Theodorou T, Pope C, Hibbert P
NPJ Genom Med. 2023; 8(1):18.
PMID: 37524740
PMC: 10390466.
DOI: 10.1038/s41525-023-00357-w.
Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures.
Odenwald B, Brockow I, Hanauer M, Luders A, Nennstiel U
Int J Neonatal Screen. 2023; 9(3).
PMID: 37489488
PMC: 10366861.
DOI: 10.3390/ijns9030035.
Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?.
Vears D, Savulescu J, Christodoulou J, Wall M, Newson A
Pharmgenomics Pers Med. 2023; 16:681-691.
PMID: 37415831
PMC: 10321326.
DOI: 10.2147/PGPM.S376083.
Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America.
Giugliani R, Taucher S, Hafez S, Oliveira J, Rico-Restrepo M, Rozenfeld P
Front Genet. 2022; 13:1053559.
PMID: 36568372
PMC: 9773081.
DOI: 10.3389/fgene.2022.1053559.
From the patient to the population: Use of genomics for population screening.
Mighton C, Shickh S, Aguda V, Krishnapillai S, Adi-Wauran E, Bombard Y
Front Genet. 2022; 13:893832.
PMID: 36353115
PMC: 9637971.
DOI: 10.3389/fgene.2022.893832.
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.
Schmutzler R, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P
Breast Care (Basel). 2022; 17(2):208-223.
PMID: 35702492
PMC: 9149472.
DOI: 10.1159/000517182.
A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes.
Burlina A, Jones S, Chakrapani A, Church H, Heales S, Wu T
Int J Neonatal Screen. 2022; 8(2).
PMID: 35466196
PMC: 9036245.
DOI: 10.3390/ijns8020025.
Ethics of Reproductive Genetic Carrier Screening: From the Clinic to the Population.
Dive L, Newson A
Public Health Ethics. 2021; 14(2):202-217.
PMID: 34650621
PMC: 8510688.
DOI: 10.1093/phe/phab017.
Absorbing it all: A meta-ethnography of parents' unfolding experiences of newborn screening.
White A, Boardman F, McNiven A, Locock L, Hinton L
Soc Sci Med. 2021; 287():114367.
PMID: 34534781
PMC: 8505793.
DOI: 10.1016/j.socscimed.2021.114367.
Newborn screening for carnitine transporter defect in Bavaria and the long-term follow-up of the identified newborns and mothers: Assessing the benefit and possible harm based on 19 ½ years of experience.
Schiergens K, Weiss K, Roschinger W, Lotz-Havla A, Schmitt J, Dalla Pozza R
Mol Genet Metab Rep. 2021; 28:100776.
PMID: 34178604
PMC: 8214137.
DOI: 10.1016/j.ymgmr.2021.100776.
Half a Century of Wilson & Jungner: Reflections on the Governance of Population Screening.
Sturdy S, Miller F, Hogarth S, Armstrong N, Chakraborty P, Cressman C
Wellcome Open Res. 2020; 5:158.
PMID: 32923689
PMC: 7468564.
DOI: 10.12688/wellcomeopenres.16057.2.
Consolidated principles for screening based on a systematic review and consensus process.
Dobrow M, Hagens V, Chafe R, Sullivan T, Rabeneck L
CMAJ. 2018; 190(14):E422-E429.
PMID: 29632037
PMC: 5893317.
DOI: 10.1503/cmaj.171154.
How is genetic testing evaluated? A systematic review of the literature.
Pitini E, De Vito C, Marzuillo C, DAndrea E, Rosso A, Federici A
Eur J Hum Genet. 2018; 26(5):605-615.
PMID: 29422659
PMC: 5945588.
DOI: 10.1038/s41431-018-0095-5.
Newborn bloodspot screening policy framework for Australia.
OLeary P, Maxwell S
Australas Med J. 2015; 8(9):292-8.
PMID: 26464586
PMC: 4592945.
DOI: 10.4066/AMJ.2015.2482.